Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2008 1
2009 1
2011 2
2012 3
2013 4
2014 6
2015 3
2016 4
2017 4
2018 3
2019 1
2020 2
2021 1
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
NMDAR antagonists suppress tumor progression by regulating tumor-associated macrophages.
Yuan D, Hu J, Ju X, Putz EM, Zheng S, Koda S, Sun G, Deng X, Xu Z, Nie W, Zhao Y, Li X, Dougall WC, Shao S, Chen Y, Tang R, Zheng K, Yan J. Yuan D, et al. Among authors: putz em. Proc Natl Acad Sci U S A. 2023 Nov 21;120(47):e2302126120. doi: 10.1073/pnas.2302126120. Epub 2023 Nov 15. Proc Natl Acad Sci U S A. 2023. PMID: 37967215
Bench to bedside: NK cells and control of metastasis.
Krasnova Y, Putz EM, Smyth MJ, Souza-Fonseca-Guimaraes F. Krasnova Y, et al. Among authors: putz em. Clin Immunol. 2017 Apr;177:50-59. doi: 10.1016/j.clim.2015.10.001. Epub 2015 Oct 23. Clin Immunol. 2017. PMID: 26476139 Review.
High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma.
Grissenberger S, Sturtzel C, Wenninger-Weinzierl A, Radic-Sarikas B, Scheuringer E, Bierbaumer L, Etienne V, Némati F, Pascoal S, Tötzl M, Tomazou EM, Metzelder M, Putz EM, Decaudin D, Delattre O, Surdez D, Kovar H, Halbritter F, Distel M. Grissenberger S, et al. Among authors: putz em. Cancer Lett. 2023 Feb 1;554:216028. doi: 10.1016/j.canlet.2022.216028. Epub 2022 Dec 1. Cancer Lett. 2023. PMID: 36462556 Free article.
NK Cell-Specific CDK8 Deletion Enhances Antitumor Responses.
Witalisz-Siepracka A, Gotthardt D, Prchal-Murphy M, Didara Z, Menzl I, Prinz D, Edlinger L, Putz EM, Sexl V. Witalisz-Siepracka A, et al. Among authors: putz em. Cancer Immunol Res. 2018 Apr;6(4):458-466. doi: 10.1158/2326-6066.CIR-17-0183. Epub 2018 Jan 31. Cancer Immunol Res. 2018. PMID: 29386186
STAT1-S727 - the license to kill.
Putz EM, Gotthardt D, Sexl V. Putz EM, et al. Oncoimmunology. 2014 Dec 13;3(9):e955441. doi: 10.4161/21624011.2014.955441. eCollection 2014 Oct. Oncoimmunology. 2014. PMID: 25941617 Free PMC article.
Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study.
Fuereder T, Minichsdorfer C, Mittlboeck M, Wagner C, Heller G, Putz EM, Oberndorfer F, Müllauer L, Aretin MB, Czerny C, Schwarz-Nemec U. Fuereder T, et al. Among authors: putz em. Oral Oncol. 2022 Jan;124:105634. doi: 10.1016/j.oraloncology.2021.105634. Epub 2021 Nov 26. Oral Oncol. 2022. PMID: 34844042 Free article. Clinical Trial.
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.
Porpaczy E, Tripolt S, Hoelbl-Kovacic A, Gisslinger B, Bago-Horvath Z, Casanova-Hevia E, Clappier E, Decker T, Fajmann S, Fux DA, Greiner G, Gueltekin S, Heller G, Herkner H, Hoermann G, Kiladjian JJ, Kolbe T, Kornauth C, Krauth MT, Kralovics R, Muellauer L, Mueller M, Prchal-Murphy M, Putz EM, Raffoux E, Schiefer AI, Schmetterer K, Schneckenleithner C, Simonitsch-Klupp I, Skrabs C, Sperr WR, Staber PB, Strobl B, Valent P, Jaeger U, Gisslinger H, Sexl V. Porpaczy E, et al. Among authors: putz em. Blood. 2018 Aug 16;132(7):694-706. doi: 10.1182/blood-2017-10-810739. Epub 2018 Jun 14. Blood. 2018. PMID: 29907599 Free PMC article.
Bcl-2: Live and let die.
Putz EM, Schuster C, Sexl V. Putz EM, et al. Oncoimmunology. 2012 Aug 1;1(5):749-750. doi: 10.4161/onci.19536. Oncoimmunology. 2012. PMID: 22934270 Free PMC article.
38 results